Abbvie Stock Financials

ABBV
 Stock
  

USD 140.29  3.04  2.12%   

We suggest to use Abbvie Inc fundamental analysis to see if markets are presently undervaluing or overvaluing the company. Put another way, you can use it to find out if Abbvie Inc is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We have analyzed thirty-eight available fundamental indicators for Abbvie Inc, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all Abbvie Inc financials, including its shares outstanding, net income, price to earnings to growth, as well as the relationship between the price to book and current ratio . Given that Abbvie Inc has a price to earning of 49.20 X, we suggest you to validate Abbvie Inc prevailing market performance to make sure the company can sustain itself down the road. Use Abbvie to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Abbvie to be traded at $134.68 in 90 days.
  
With this module, you can analyze Abbvie financials for your investing period. You should be able to track the changes in Abbvie individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Understanding current and past Abbvie Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Abbvie's financial statements are interrelated, with each one affecting the others. For example, an increase in Abbvie's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Less than 33
Abbvie Inc has less than 33 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Abbvie stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Abbvie's official financial statements usually reflect Abbvie's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Abbvie Inc. For example, before you start analyzing numbers published by Abbvie accountants, it's critical to develop an understanding of what Abbvie's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Abbvie's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Abbvie's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Abbvie's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Abbvie Inc. Please utilize our Beneish M Score to check the likelihood of Abbvie's management to manipulate its earnings.

Abbvie Company Summary

Abbvie competes with Amazon. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. Abbvie operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 50000 people.
Foreign Associates
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
Business Address1 North Waukegan
SectorHealthcare
IndustryDrug Manufacturers—General
BenchmarkDOW
Websitewww.abbvie.com
Phone847 932 7900
CurrencyUSD - US Dollar
You should never invest in Abbvie without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Abbvie Stock, because this is throwing your money away. Analyzing the key information contained in Abbvie's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Abbvie Key Financial Ratios

Generally speaking, Abbvie's financial ratios allow both analysts and investors to convert raw data from Abbvie's financial statements into concise, actionable information that can be used to evaluate the performance of Abbvie over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Abbvie Inc reports annually and quarterly.

Abbvie Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Abbvie's current stock value. Our valuation model uses many indicators to compare Abbvie value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abbvie competition to find correlations between indicators driving Abbvie's intrinsic value. More Info.
Abbvie Inc is number one stock in number of employees category among related companies. It is the top company in revenue category among related companies totaling about  1,147,000  of Revenue per Number of Employees. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Abbvie by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Abbvie's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abbvie's earnings, one of the primary drivers of an investment's value.

Abbvie Inc Systematic Risk

Abbvie's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Abbvie volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Abbvie Inc correlated with the market. If Beta is less than 0 Abbvie generally moves in the opposite direction as compared to the market. If Abbvie Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Abbvie Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Abbvie is generally in the same direction as the market. If Beta > 1 Abbvie moves generally in the same direction as, but more than the movement of the benchmark.
.

About Abbvie Financials

What exactly are Abbvie Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Abbvie's income statement, its balance sheet, and the statement of cash flows. Potential Abbvie investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Abbvie investors may use each financial statement separately, they are all related. The changes in Abbvie's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Abbvie's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Abbvie is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Abbvie has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Abbvie Thematic Clasifications

Abbvie Inc is part of several thematic ideas from Giant Impact to Macroaxis Index. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Giant Impact Idea
Giant ImpactView
Macroaxis Index Idea
Macroaxis IndexView
Drugs Idea
DrugsView

Abbvie October 7, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Abbvie help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Abbvie Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Abbvie Inc based on widely used predictive technical indicators. In general, we focus on analyzing Abbvie Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Abbvie's daily price indicators and compare them against related drivers.
Information Ratio(0.034312)
Maximum Drawdown8.93
Value At Risk(2.61)
Potential Upside2.12
Please continue to Trending Equities. Note that the Abbvie Inc information on this page should be used as a complementary analysis to other Abbvie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Abbvie Stock analysis

When running Abbvie Inc price analysis, check to measure Abbvie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbvie is operating at the current time. Most of Abbvie's value examination focuses on studying past and present price action to predict the probability of Abbvie's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbvie's price. Additionally, you may evaluate how the addition of Abbvie to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Is Abbvie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbvie. If investors know Abbvie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbvie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Abbvie Inc is measured differently than its book value, which is the value of Abbvie that is recorded on the company's balance sheet. Investors also form their own opinion of Abbvie's value that differs from its market value or its book value, called intrinsic value, which is Abbvie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbvie's market value can be influenced by many factors that don't directly affect Abbvie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbvie's value and its price as these two are different measures arrived at by different means. Investors typically determine Abbvie value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbvie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.